GCA
BEAT

Greenwood Capital Associates’s BioTelemetry, Inc. BEAT Stock Holding History

Greenwood Capital Associates’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,366
Closed -$217K – 223
2018
Q3 		$217K Buy
+3,366
New +$188K 0.05% 176

Other funds holding BEAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Greenwood Capital Associates's BEAT Position: Q4 2018 in Review

Greenwood Capital Associates sold out of BioTelemetry, Inc. (BEAT) in Q4 2018, closing a stake of 3,366 shares — an estimated $217K sold.

Greenwood Capital Associates first reported a position in BEAT in Q3 2018 and held it in 1 quarter. The position peaked at $217K in Q3 2018. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

  • Greenwood Capital Associates reported no remaining BioTelemetry, Inc. position as of Q4 2018 after selling out during the quarter.
  • Greenwood Capital Associates sold 3,366 BioTelemetry, Inc. shares in Q4 2018, an estimated $217K.
  • Greenwood Capital Associates first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 1 quarter.
  • Greenwood Capital Associates's BioTelemetry, Inc. position peaked at $217K in Q3 2018.
  • 281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on Greenwood Capital Associates's 13F filing for Q4 2018, filed 11 Feb 2019.